FDA Plans Tighter Scrutiny Of Off-Label Data Sent To Doctors
By Dan McKay · October 25, 2023, 8:02 PM EDT
The U.S. Food and Drug Administration is preparing more stringent guidelines on how pharmaceutical companies and similar firms should communicate with doctors about research into the off-label use of medical devices...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login